Results 1 to 10 of about 9,713 (136)

Drug development concerning metallo-β-lactamases in gram-negative bacteria [PDF]

open access: yesFrontiers in Microbiology, 2022
β-Lactams have been a clinical focus since their emergence and indeed act as a powerful tool to combat severe bacterial infections, but their effectiveness is threatened by drug resistance in bacteria, primarily by the production of serine- and metallo-β-
Hefeng Wang, Li Xiuyun
exaly   +4 more sources

Evolution of Metallo-β-lactamases: Trends Revealed by Natural Diversity and in vitro Evolution

open access: yesAntibiotics, 2014
The production of β-lactamase enzymes is one of the most distributed resistance mechanisms towards β-lactam antibiotics. Metallo-β-lactamases constitute a worrisome group of these kinds of enzymes, since they present a broad spectrum profile, being able
Leticia Llarrull   +2 more
exaly   +3 more sources

Dynamically chiral phosphonic acid-type metallo-β-lactamase inhibitors

open access: yesCommunications Chemistry
Antibiotic resistance is a growing global health threat that risks the lives of millions. Among the resistance mechanisms, that mediated by metallo-β-lactamases is of particular concern as these bacterial enzymes dismantle most β-lactam antibiotics ...
Kinga Virág Gulyás   +19 more
doaj   +6 more sources

Antifungal agent tavaborole as a potential broad-spectrum serine and metallo-β-lactamases inhibitorResearch in context [PDF]

open access: yesEBioMedicine
Summary: Background: The global emergence and spread of carbapenem-resistant Enterobacteriaceae in clinical settings have driven the search for inhibitors that can counteract carbapenemases.
Yan Zhang   +15 more
doaj   +2 more sources

Specific Protein-Membrane Interactions Promote Packaging of Metallo-β-Lactamases into Outer Membrane Vesicles [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2021
Lisandro Gonzalez   +2 more
exaly   +2 more sources

Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods

open access: yesScientific Reports, 2021
New Delhi metallo-β-lactamase variants and different types of metallo-β-lactamases have attracted enormous consideration for hydrolyzing almost all β-lactam antibiotics, which leads to multi drug resistance bacteria.
Azhar Salari-jazi   +4 more
doaj   +1 more source

Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016–2022

open access: yesEmerging Infectious Diseases, 2023
Controlling the spread of carbapenem-resistant Enterobacterales is a global priority. Using National Healthcare Safety Network data, we characterized the changing epidemiology of carbapenem-resistant Klebsiella pneumoniae (CRKP) in a large public health
Jennifer Lee   +7 more
doaj   +1 more source

Faropenem reacts with serine and metallo-β-lactamases to give multiple products [PDF]

open access: yesEuropean Journal of Medicinal Chemistry, 2021
Philip Hinchliffe   +2 more
exaly   +2 more sources

Novel metallo β-lactamase mediated by aShigella flexneriplasmid [PDF]

open access: yesFEMS Microbiology Letters, 1998
Novel carbapenem-hydrolyzing beta-lactamase (newly named MET-1) encoded on a transferable plasmid pMS390 from Shigella flexneri JS19622 was purified. The molecular weight was 28,000 by SDS-PAGE and the isoelectric point was higher than 9.3. This beta-lactamase favorably hydrolyzed classical cephalosporins and oxyimino-cephalosporins rather than ...
K, O'Hara   +4 more
openaire   +2 more sources

Could β-Lactam Antibiotics Block Humoral Immunity?

open access: yesFrontiers in Immunology, 2021
It has been reported that treatment with β-lactam antibiotics induces leukopenia and candidemia, worsens the clinical response to anticancer immunotherapy and decreases immune response to vaccination.
Cléa Melenotte   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy